Ptc Therapeutics Inc Net Income per Employee (PTCT), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Ptc Therapeutics inc   (NASDAQ: PTCT)
 

Ptc Therapeutics Inc Net Income per Employee

PTCT's Quarterly Results, Trends, Rankings, Statistics
Ptc Therapeutics Inc recorded a cumulative net loss of $-105 million during 12 month ending in the third quarter 2026.
The Healthcare sector has seen employees of 104 other companies achieving higher income per employee. While Ptc Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 344 to 3199.


What is Income per Employee Ratio?






PTCT Net Income per Employee (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -105,966 -37,763 -188,423 688,844 758,550
PTCT's Total Ranking # 3199 # 344 # 239 # 242 # 252
Seq. Net Income Change - - - - -


PTCT Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 105
Healthcare Sector # 362
Overall Market # 3199

Net Income per Employee Statistics
High Average Low
$ 758,550 $ -205,503 $ -647,529
(Sep 30 2025)   (Sep 30 2023)







Companies with similar Income per Employee for 12 month ending Sep 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2026Number of Employees Sep 30 2026


Date modified: 2026-10-30T13:21:26+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.